Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Insider Activity and Strategic Developments at Sensei Biotherapeutics Signal Potential Valuation Discrepancy

Insider Activity and Strategic Developments at Sensei Biotherapeutics Signal Potential Valuation Discrepancy

Filings indicate significant mixed trading activity in Sensei Biotherapeutics (SNSE) common stock between late March 2026. While reporting persons executed sales totaling roughly $89,389, they simultaneously acquired shares valued at approximately $818,257. This insider activity occurs while SNSE trades at $20.43 and is noted for its high volatilit…

Director Thomas Lehrman Sells Significant Shares of Ibotta; Company Faces Mixed Signals Amid Analyst Upgrades and Quarterly Miss

Director Thomas Lehrman Sells Significant Shares of Ibotta; Company Faces Mixed Signals Amid Analyst Upgrades and Quarterly Miss

Ibotta's Director Thomas D Lehrman recently reported the sale of shares totaling over $1 million worth of Class A Common Stock via SEC filings. This selling activity occurred as the company experienced fluctuating stock performance and presented mixed financial results in its Q1 2026 earnings, including a notable Earnings Per Share (EPS) miss compa…

PubMatic CEO Sells Shares Amid Recent Quarterly Earnings Beat

PubMatic CEO Sells Shares Amid Recent Quarterly Earnings Beat

Rajeev K. Goel, Chief Executive Officer of PubMatic, Inc., recently completed a significant sale of company stock totaling approximately $420,270. This transaction involved 44,000 shares of Class A Common Stock, sold at an average price of $9.5516 per share. The sale was structured through a pre-arranged Rule 10b5-1 trading plan, which Mr. Goel had…

Executive Stock Activity and Recent Earnings Data for INSMED Inc.

Executive Stock Activity and Recent Earnings Data for INSMED Inc.

Sara Bonstein, CFO of INSMED Inc., sold a significant block of company stock in recent filings. This activity occurred while the company's stock has demonstrated notable volatility and experienced fluctuating performance metrics year-to-date. Despite this, Insmed reported first-quarter 2026 earnings that surpassed Wall Street estimates for both EPS…

Matson SVP's Stock Sale Occurs Amid Mixed Q1 Earnings Report

Matson SVP's Stock Sale Occurs Amid Mixed Q1 Earnings Report

Senior Vice President Jason Lee Taylor sold a block of company shares in May 2026. This transaction occurred against the backdrop of Matson's recent first-quarter 2026 earnings release, which displayed mixed financial signals: EPS exceeded expectations but revenue fell short of analyst forecasts. Investors are closely monitoring these conflicting r…

Insider Buying at TON Strategy Co Amid Mixed Financial Signals

Insider Buying at TON Strategy Co Amid Mixed Financial Signals

TON Strategy Co's CEO, Kevin Mark Wilson, recently acquired a block of common stock, suggesting internal confidence. This purchase occurs against a backdrop where the company reported significant financial losses for the first quarter of 2026, primarily linked to unrealized gains on its Toncoin holdings. Analysis also points out that while the stoc…